Wellington Management Group LLP Sells 169,992 Shares of Addus HomeCare Corporation $ADUS

Wellington Management Group LLP decreased its holdings in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 44.5% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 212,362 shares of the company’s stock after selling 169,992 shares during the period. Wellington Management Group LLP’s holdings in Addus HomeCare were worth $21,336,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of ADUS. Leeward Investments LLC MA grew its holdings in Addus HomeCare by 9.4% during the 1st quarter. Leeward Investments LLC MA now owns 120,857 shares of the company’s stock worth $11,318,000 after acquiring an additional 10,414 shares during the period. Summit Creek Advisors LLC bought a new stake in shares of Addus HomeCare during the 2nd quarter valued at $8,552,000. Bank of America Corp DE lifted its stake in shares of Addus HomeCare by 11.3% in the 1st quarter. Bank of America Corp DE now owns 323,037 shares of the company’s stock valued at $30,252,000 after purchasing an additional 32,714 shares during the period. Vanguard Group Inc. lifted its stake in shares of Addus HomeCare by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock valued at $140,531,000 after purchasing an additional 10,501 shares during the period. Finally, TimesSquare Capital Management LLC bought a new position in shares of Addus HomeCare in the 2nd quarter worth $31,502,000. 95.35% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Weiss Ratings raised Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Royal Bank Of Canada raised their target price on Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Barclays boosted their target price on Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research report on Wednesday, July 8th. Citizens Jmp reaffirmed a “market outperform” rating and issued a $142.00 price target on shares of Addus HomeCare in a research note on Monday, May 18th. Finally, Citigroup reiterated a “market outperform” rating on shares of Addus HomeCare in a research report on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $128.86.

Addus HomeCare Price Performance

Shares of Addus HomeCare stock opened at $118.76 on Monday. The company has a market capitalization of $2.22 billion, a P/E ratio of 20.84, a price-to-earnings-growth ratio of 1.59 and a beta of 0.86. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.69 and a quick ratio of 1.69. The business has a 50-day moving average of $114.01 and a two-hundred day moving average of $103.13. Addus HomeCare Corporation has a 1 year low of $87.95 and a 1 year high of $124.43.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, beating the consensus estimate of $1.70 by $0.03. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.The business had revenue of $377.41 million for the quarter, compared to analysts’ expectations of $376.24 million. During the same quarter in the previous year, the business posted $1.49 EPS. Addus HomeCare’s revenue for the quarter was up 8.0% on a year-over-year basis. As a group, equities analysts predict that Addus HomeCare Corporation will post 6.3 EPS for the current year.

Insider Buying and Selling

In other news, insider Heather Dixon sold 288 shares of the stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the sale, the insider owned 44,371 shares of the company’s stock, valued at $4,160,668.67. This represents a 0.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 4.10% of the company’s stock.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.